About Us  |  Contact Us  |  Español
VNA of Care New England
VNA of Care New England

Antibiotic Protocol Selects Against Drug Resistance

Treatment cycles between compatible antibiotics
THURSDAY, Sept. 26 (HealthDay News) -- Cycling between antibiotics can select against the development of drug resistance, according to a study published in the Sept. 25 issue of Science Translational Medicine.
Lejla Imamovic, Ph.D., and Morten O.A. Sommer, Ph.D., from the Technical University of Denmark in Lyngby, evolved parallel lineages of Escherichia coli that were resistant to 23 clinically relevant antibiotics from 11 chemical classes and mechanisms of action, and then examined their sensitivity to other antibiotics.
The researchers found that E. coli strains that were resistant to one antibiotic became sensitive to another antibiotic. Antibiotics with compatible "collateral sensitivity" profiles such as gentamicin and cefuroxime were used to sequentially treat E. coli infection and used cyclically to select against the development of drug resistance. The results were validated in related bacterial pathogens.
"These results provide proof of principle for collateral sensitivity cycling as a sustainable treatment paradigm that may be generally applicable to infectious diseases and cancer," Imamovic and Sommer conclude.
Sommer is a founder of several companies with competing financial interests.
Abstract (http://stm.sciencemag.org/content/5/204/204ra132 )Full Text (http://stm.sciencemag.org/content/5/204/204ra132.full )
Health Headlines
Health Highlights: April 18, 2014View in a lightbox
Health Tip: Avoid Driving During Flood WarningView in a lightbox
Health Tip: If Your Child is ConstipatedView in a lightbox
Oil-Swishing Craze: Snake Oil or All-Purpose Remedy?View in a lightbox
Suddenly Health Insurance Is Not for SaleView in a lightbox
VNA of Care New England
© 2011 Site Index | Disclaimer | Legal Notices